PERCUTANEOUS DELIVERY OF PROTEINS AND PEPTIDES USING IONTOPHORETIC TECHNIQUES

Journal of Clinical Pharmacy and Therapeutics

Volumn 16, Issue 1, 1991, Pages 7-17

  Parasrampuria, D ^a   Parasrampuria, J ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PROTEIN;

DRUG DELIVERY SYSTEM; HUMAN; IONTOPHORESIS; REVIEW; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; HUMAN; IONTOPHORESIS; PEPTIDES; PROTEINS;

EID: 0025979759     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.1991.tb00278.x     Document Type: Review

References (52)

1. Direct current iontophoretic transdermal delivery of peptide and protein drugs
2. The skin
3. The permeability of skin to some non‐electrolytes
4. Penetration of low‐molecular‐weight alcohols into skin. I: Effect of concentration of alcohol and type of vehicle
5. Mechanism of percutaneous absorption. I: Routes of penetration and the influence of solubility
6. Parameters of skin condition and function
7. Physiocochemical aspects of percutaneous penetration and its enhancement
8. Role of stratum corneum lipid fluidity in transdermal drug flux
9. Parenteral formulations of proteins and peptides: stability and stabilizers
10. Peptides and protein drug delivery: opportunities and challenges
11. Nonparenteral administration of peptide and protein drugs
12. Facilitated transdermal transport of insulin
13. Transdermal iontophoretic delivery of insulin for blood glucose control in diabetic rabbits
14. Iontophoresis and promoted drug absorption
15. Potential novel methods for insulin administration: iontophoresis
16. Electro‐osmotic transdermal drug delivery
17. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin
18. Iontophoretic (transdermal) delivery of drugs: overview of historic development
19. Iontophoretic devices for drug delivery
20. Pharmacy of topical drugs
21. Increased penetration of nonelectrolytes into mouse skin during iontophoretic water transport (iontohydrokinesis)
22. Transdermal delivery of propranolol via iontophoresis
23. New iontophoretic transdermal administration of the betablocker metoprolol
24. Transdermal delivery of oxycodone I: animal models, passive diffusion and facilitated transport with iontophoresis
25. Transdermal iontophoretic delivery of therapeutic peptides/proteins I. Insulin
26. Iontophoresis‐facilitated transdermal delivery of verapamil: in vitro evaluation and mechanistic studies
27. Iontophoretic application of drugs
28. Enhanced percutaneous absorption via iotophoresis I. Evaluation of an in vitro system and transport of model compounds
29. Copper iontophoresis in male contraception
30. The skin as a drug metabolizing organ
31. Introduction of antiinflammatory drugs by iontophoresis: double blind study
32. Iontophretic assistance of 5‐iodo‐2'‐deoxyuridine penetration into neonatal mouse skin and effects on DNA synthesis
33. Effect of iontophoresis of vasopressin on lateral septal neurons
34. Iontophoretic application of antiviral chemotherapeutic agents
35. Iontophoretic devices
36. Electrical properties of the epidermal stratum corneum
37. Electrical characteristics of the skin: The impedence of the surface sheath and deep tissues
38. Conformational requirements for the potential dependent pore formation of the peptide antibioticalamethicin, suzukacillin and trichotoxin
39. Iontophoresis
40. Skin reactions IX. The electrophoretic demonstration of the patent pores of the living human skin; its relation to the charge of the skin
41. Examination of iontophoretic transport of ionic drug across skin. I. baseline studies with four electrode systems
42. Transdermal controlled release drug administration
43. Iontophoretic delivery of drugs: Fundamentals, development and biomedical applications
44. Influence of some physical chemical factors on iontophoresis using radio‐isotopes
45. Reversible electrodes
46. Electromotive force and oxidation‐reduction systems
47. Iontophoretic burn‐protection electrode structure
48. Iontophoretic burn‐protection method
49. Iontophoresis device
50. Iontophoresis in dermatology
51. Transdermal drug delivery—problems and promises
52. Iontophoretic drug delivery: effects of physicochemical factors on the skin uptake of nonpeptide drugs